Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

Relitect

Relitect

Home > Companies > Relitect

Relitect are developing a novel technology for the detection of binding events, which can be used for the analysis of proteins, small molecules and nucleic acids.

 

The Relitect proprietary technology enables highly sensitive detection of biomarkers or other analytes in a label free multiplexed format, using small sample volumes.

 

Relitect’s approach has potential for utilisation across the clinical diagnostics and life sciences industries.